BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17137389)

  • 1. Chemoselective protection of solid-phase compatible Fmoc-phosphinic building blocks.
    Nasopoulou M; Matziari M; Dive V; Yiotakis A
    J Org Chem; 2006 Dec; 71(25):9525-7. PubMed ID: 17137389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortcut to fmoc-protected phosphinic pseudodipeptidic blocks.
    Matziari M; Yiotakis A
    Org Lett; 2005 Sep; 7(18):4049-52. PubMed ID: 16119964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A versatile annulation protocol toward novel constrained phosphinic peptidomimetics.
    Nasopoulou M; Georgiadis D; Matziari M; Dive V; Yiotakis A
    J Org Chem; 2007 Sep; 72(19):7222-8. PubMed ID: 17715974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
    Ye Y; Liu M; Kao JL; Marshall GR
    Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of p-aminophenyl aryl H-phosphinic acids and esters via cross-coupling reactions: elaboration to phosphinic acid pseudopeptide analogues of pteroyl glutamic acid and related antifolates.
    Yang Y; Coward JK
    J Org Chem; 2007 Jul; 72(15):5748-58. PubMed ID: 17602593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
    Matziari M; Bauer K; Dive V; Yiotakis A
    J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of the Hydroxyphosphinyl Function of Phosphinic Dipeptides by Adamantyl. Application to the Solid-Phase Synthesis of Phosphinic Peptides.
    Yiotakis A; Vassiliou S; Jirácek J; Dive V
    J Org Chem; 1996 Sep; 61(19):6601-6605. PubMed ID: 11667528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase synthesis of "mixed" peptidomimetics using Fmoc-protected aza-beta3-amino acids and alpha-amino acids.
    Busnel O; Bi L; Dali H; Cheguillaume A; Chevance S; Bondon A; Muller S; Baudy-Floc'h M
    J Org Chem; 2005 Dec; 70(26):10701-8. PubMed ID: 16355988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Backbone amide linker (BAL) strategy for Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) solid-phase synthesis of peptide aldehydes.
    Kappel JC; Barany G
    J Pept Sci; 2005 Sep; 11(9):525-35. PubMed ID: 16001455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase synthesis of N-nosyl- and N-Fmoc-N-methyl-alpha-amino acids.
    Di Gioia ML; Leggio A; Liguori A; Perri F
    J Org Chem; 2007 May; 72(10):3723-8. PubMed ID: 17439178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient route for the synthesis of glycosyl phosphinic acids.
    Centrone CA; Lowary TL
    J Org Chem; 2003 Oct; 68(21):8115-9. PubMed ID: 14535792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caged phospho-amino acid building blocks for solid-phase peptide synthesis.
    Rothman DM; Vazquez ME; Vogel EM; Imperiali B
    J Org Chem; 2003 Aug; 68(17):6795-8. PubMed ID: 12919051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastereoselective synthesis of (+/-)-(3-aminocyclopentane)alkylphosphinic acids, conformationally restricted analogues of GABA.
    Hanrahan JR; Mewett KN; Chebib M; Matos S; Eliopoulos CT; Crean C; Kumar RJ; Burden P; Johnston GA
    Org Biomol Chem; 2006 Jul; 4(13):2642-9. PubMed ID: 16791329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-keto amide peptides: a synthetic strategy to resin-bound peptide isosteres for protease inhibitor screening on solid support.
    Papanikos A; Meldal M
    J Comb Chem; 2004; 6(2):181-95. PubMed ID: 15002966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fmoc solid-phase synthesis of peptide thioesters by masking as trithioortho esters.
    Brask J; Albericio F; Jensen KJ
    Org Lett; 2003 Aug; 5(16):2951-3. PubMed ID: 12889916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of in situ silylation for improved, convenient preparation of fluorenylmethoxycarbonyl (Fmoc)-protected phosphinate amino acids.
    Li S; Whitehead JK; Hammer RP
    J Org Chem; 2007 Apr; 72(8):3116-8. PubMed ID: 17375960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient synthesis of Fmoc-protected phosphinic pseudodipeptides: Building blocks for the synthesis of matrix metalloproteinase inhibitors.
    Bhowmick M; Sappidi RR; Fields GB; Lepore SD
    Biopolymers; 2011; 96(1):1-3. PubMed ID: 20225219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastereoselective solution and multipin-based combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitors.
    Makaritis A; Georgiadis D; Dive V; Yiotakis A
    Chemistry; 2003 May; 9(9):2079-94. PubMed ID: 12740857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of α-carboxyphosphinopeptides derived from norleucine.
    Pícha J; Buděšínský M; Fiedler P; Sanda M; Jiráček J
    Amino Acids; 2010 Nov; 39(5):1265-80. PubMed ID: 20349321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the synthetic route to pepstatin analogues by SPPS using O-protected and O-unprotected statine as building blocks.
    Cadicamo CD; Asante V; Abu Ammar M; Borelli C; Korting HC; Koksch B
    J Pept Sci; 2009 Apr; 15(4):272-7. PubMed ID: 19189272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.